Descriptor English: | Dobutamine | ||||
Descriptor Spanish: |
Dobutamina
| ||||
Descriptor Portuguese: | Dobutamina | ||||
Descriptor French: | Dobutamine | ||||
Entry term(s): |
Dobucor Dobuject Dobutamin Fresenius Dobutamin Hexal Dobutamin Solvay Dobutamin ratiopharm Dobutamin-ratiopharm Dobutamina Inibsa Dobutamina Rovi Dobutamine (+)-Isomer Dobutamine Hydrobromide Dobutamine Hydrochloride Dobutamine Lactobionate Dobutamine Phosphate (1:1) Salt, (-)-Isomer Dobutamine Tartrate Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer Dobutamine, (-)-Isomer Dobutamine, Phosphate (1:1) Salt (+)-Isomer Dobutrex Hydrobromide, Dobutamine Hydrochloride, Dobutamine Lactobionate, Dobutamine Lilly 81929 Oxiken Posiject Tartrate, Dobutamine |
||||
Tree number(s): |
D02.092.311.220 D02.092.471.683.410 D02.455.426.559.389.657.166.175.220 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D004280 | ||||
Scope note: | A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Cardiotonic Agents Sympathomimetics Adrenergic beta-1 Receptor Agonists |
||||
Registry Number: | 3S12J47372 | ||||
CAS Type 1 Name: | 1,2-Benzenediol, 4-(2-((3-(4-hydroxyphenyl)-1-methylpropyl)amino)ethyl)-, (+-)- | ||||
Previous Indexing: |
Catecholamines (1974-1975) Phenethylamines (1974-1975) Phenols (1974-1975) |
||||
Public MeSH Note: | 86; was see under CATECHOLAMINES 1976-85 |
||||
History Note: | 86(76); was see under CATECHOLAMINES 1976-85 |
||||
DeCS ID: | 4341 | ||||
Unique ID: | D004280 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1986/01/01 | ||||
Date of Entry: | 1975/07/18 | ||||
Revision Date: | 2018/06/30 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals
|
Dobutamine
- Preferred
Dobucor
- Narrower
Dobuject
- Narrower
Dobutamin Fresenius
- Narrower
Dobutamin Hexal
- Narrower
Dobutamin Solvay
- Narrower
Dobutamin-ratiopharm
- Narrower
Dobutamina Inibsa
- Narrower
Dobutamina Rovi
- Narrower
Posiject
- Narrower
Dobutamine Hydrobromide
- Narrower
Dobutamine Hydrochloride
- Narrower
Dobutamine Lactobionate
- Narrower
Dobutamine Tartrate
- Narrower
Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer
- Narrower
Dobutamine, (-)-Isomer
- Narrower
Dobutamine, Phosphate (1:1) Salt (+)-Isomer
- Narrower
Dobutrex
- Narrower
Lilly 81929
- Narrower
Oxiken
- Narrower
Dobutamine Phosphate (1:1) Salt, (-)-Isomer
- Narrower
Dobutamine (+)-Isomer
- Narrower
Concept UI |
M0006696 |
Scope note | A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. |
Preferred term | Dobutamine |
Concept UI |
M0485249 |
Preferred term | Dobucor |
Concept UI |
M0485248 |
Preferred term | Dobuject |
Concept UI |
M0485247 |
Preferred term | Dobutamin Fresenius |
Concept UI |
M0485246 |
Preferred term | Dobutamin Hexal |
Concept UI |
M0485245 |
Preferred term | Dobutamin Solvay |
Concept UI |
M0485255 |
Preferred term | Dobutamin-ratiopharm |
Entry term(s) |
Dobutamin ratiopharm |
Concept UI |
M0485253 |
Preferred term | Dobutamina Inibsa |
Concept UI |
M0485252 |
Preferred term | Dobutamina Rovi |
Concept UI |
M0485250 |
Preferred term | Posiject |
Concept UI |
M0330494 |
Preferred term | Dobutamine Hydrobromide |
Entry term(s) |
Hydrobromide, Dobutamine |
Concept UI |
M0330490 |
Preferred term | Dobutamine Hydrochloride |
Entry term(s) |
Hydrochloride, Dobutamine |
Concept UI |
M0330484 |
Preferred term | Dobutamine Lactobionate |
Entry term(s) |
Lactobionate, Dobutamine |
Concept UI |
M0330483 |
Preferred term | Dobutamine Tartrate |
Entry term(s) |
Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer Tartrate, Dobutamine |
Concept UI |
M0330485 |
Preferred term | Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer |
Concept UI |
M0330492 |
Preferred term | Dobutamine, (-)-Isomer |
Concept UI |
M0330487 |
Preferred term | Dobutamine, Phosphate (1:1) Salt (+)-Isomer |
Concept UI |
M0006697 |
Preferred term | Dobutrex |
Concept UI |
M0363611 |
Preferred term | Lilly 81929 |
Concept UI |
M0485251 |
Preferred term | Oxiken |
Concept UI |
M0330486 |
Preferred term | Dobutamine Phosphate (1:1) Salt, (-)-Isomer |
Concept UI |
M0330491 |
Preferred term | Dobutamine (+)-Isomer |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey